Rejeunesse Fine
Medical-grade Hyaluronic Acid Filler with UPHEC™ Technology | 98.7% BDDE Reduction | 24mg/ml HA Concentration
Advanced Biocompatible Formulation
Manufactured under ISO 13485 certification, Rejeunesse Fine utilizes Ultra-Purified Hyaluronic Acid with Enhanced Crosslinking (UPHEC™) technology, reducing BDDE residues to <0.2ppm (vs industry standard 5-10ppm). Contains 24mg/ml of non-animal stabilized HA with optimal particle size distribution (80-120μm) for natural tissue integration. Third-party studies demonstrate 93% patient satisfaction at 6-month follow-up with 0.38% adverse event rate (n=1,542).
Clinical Advantages
Extended Longevity
Maintains 89% volume retention at 8 months (MRI-confirmed, n=68)
Precision Viscosity
G’ modulus of 350Pa for optimal spreadability in superficial dermis
Enhanced Safety
0.3% lidocaine concentration reduces injection discomfort by 72%
Multi-Layer Correction
Effective for dermal depths 1.5-2.5mm (epidermal-dermal junction)
Product Specifications
- Composition: 24mg/ml HA + 0.3% Lidocaine
- Crosslinking: 6% BDDE (residue <0.2ppm)
- Viscosity: 350Pa at 2.5Hz oscillation
- Needle: 30G×4mm sterile cannula
- Volume: 1.1ml single-use syringe
- Storage: 2-25°C horizontal position
Clinical Protocol
- Depth: Mid-to-superficial dermis (1.5-2.5mm)
- Technique: Linear threading or serial puncture
- Dosage: 0.05-0.1ml per linear centimeter
- Anesthesia: Not required (pre-incorporated)
- Aftercare: Avoid heat exposure ×48hrs
- Touch-up: Recommend at 2-week interval
Treatment Indications
Periorbital Zone
Crow’s feet: 0.8-1.2ml per side using 30G needle. Fanning technique with retrograde injections at 30° angle. 92% improvement in Fitzpatrick Wrinkle Scale.
Mid-Face Rejuvenation
Nasolabial folds: 1.0-1.5ml per side via bolus deposition. Maintain 5mm distance from vascular structures. 8-month persistence in 87% cases.
Neck Contouring
Horizontal neck lines: 0.3ml per linear cm via 27G cannula. Superficial intradermal injection with 86% patient satisfaction rate.
Medical Advisory Notice
Important: Individual results may vary based on skin type, age, and biological response. Must be administered by board-certified dermatologists or plastic surgeons. Contraindicated in pregnancy, active skin infections, or hypersensitivity to lidocaine.
Post-treatment edema typically resolves within 72 hours. Avoid NSAIDs 48hrs pre-procedure. Document baseline photographs using Canfield VISIA® system for outcome assessment.
Reviews
There are no reviews yet.